Safety and efficacy of SNK01 (autologous natural killer cells) in combination with cytotoxic chemotherapy and/or cetuximab after failure of prior tyrosine kinase inhibitor in non-small cell lung cancer: non-clinical mouse model and phase I/IIa clinical study.
Myeong Geun ChoiGun Woo SonMi Young ChoiJae Seob JungJin Kyung RhoWonjun JiByeong Gon YoonJong-Min JoYong Man KimDae-Hyun KoJae Cheol LeeChang-Min ChoiPublished in: Journal for immunotherapy of cancer (2024)
NCT04872634.